119 related articles for article (PubMed ID: 22747829)
1. Predictors for visual dysfunction in nonfunctioning pituitary adenomas - implications for neurosurgical management.
Schmalisch K; Milian M; Schimitzek T; Lagrèze WA; Honegger J
Clin Endocrinol (Oxf); 2012 Nov; 77(5):728-34. PubMed ID: 22747829
[TBL] [Abstract][Full Text] [Related]
2. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
[TBL] [Abstract][Full Text] [Related]
3. Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study.
Honegger J; Ernemann U; Psaras T; Will B
Acta Neurochir (Wien); 2007 Jan; 149(1):21-9; discussion 29. PubMed ID: 17086476
[TBL] [Abstract][Full Text] [Related]
4. Visual field defects in patients with pituitary adenomas.
Huang WC; Lee LS
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):245-51. PubMed ID: 9509679
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions.
Berkmann S; Fandino J; Zosso S; Killer HE; Remonda L; Landolt H
J Neurosurg; 2011 Sep; 115(3):518-27. PubMed ID: 21639700
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy.
Lee S; Kim SJ; Yu YS; Kim YH; Paek SH; Kim DG; Jung HW
Br J Neurosurg; 2013 Aug; 27(4):425-9. PubMed ID: 23421587
[TBL] [Abstract][Full Text] [Related]
7. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome.
Mejico LJ; Miller NR; Dong LM
Am J Ophthalmol; 2004 May; 137(5):908-13. PubMed ID: 15126157
[TBL] [Abstract][Full Text] [Related]
8. Cognitive function surrounding resection of nonfunctioning pituitary adenomas with suprasellar extension: A prospective matched-control study.
Hendrix P; Griessenauer CJ; Hans E; Simgen A; Oertel J; Karbach J
J Clin Neurosci; 2017 Jun; 40():109-114. PubMed ID: 28284581
[TBL] [Abstract][Full Text] [Related]
9. Suprasellar extension independently predicts preoperative pituitary hormone deficiencies in patients with nonfunctioning pituitary macroadenomas: a single-center experience.
Margaritopoulos D; Vassiliadi DA; Markou M; Evangelatou E; Tzanela M; Tsagarakis S
Hormones (Athens); 2020 Jun; 19(2):245-251. PubMed ID: 32124257
[TBL] [Abstract][Full Text] [Related]
10. The pattern of visual impairment in patients with pituitary adenoma.
Wang H; Sun W; Fu Z; Si Z; Zhu Y; Zhai G; Zhao G; Xu S; Pang Q
J Int Med Res; 2008; 36(5):1064-9. PubMed ID: 18831902
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment for giant pituitary adenomas: the state of visual functions].
Kadashev BA; Faĭzullaev RB; Kalinin PL; Kutin MA; Shkarubo AN; Alekseev SN; Fomichev DV; Grigor'eva NN; Tropinskaia OF
Vestn Oftalmol; 2009; 125(2):7-10. PubMed ID: 19517822
[TBL] [Abstract][Full Text] [Related]
12. Visual pathway impairment by pituitary adenomas: quantitative diagnostics by diffusion tensor imaging.
Lilja Y; Gustafsson O; Ljungberg M; Starck G; Lindblom B; Skoglund T; Bergquist H; Jakobsson KE; Nilsson D
J Neurosurg; 2017 Sep; 127(3):569-579. PubMed ID: 27885957
[TBL] [Abstract][Full Text] [Related]
13. Chiasma syndrome in acromegalic patients--correlation of neuroradiologic and neuroophthalmologic findings.
Gnjidić Z; Iveković R; Rumboldt Z; Malenica M; Vizner B; Berković M
Coll Antropol; 2002 Dec; 26(2):601-8. PubMed ID: 12528288
[TBL] [Abstract][Full Text] [Related]
14. Pattern visual evoked potentials represent an early index for the evolution of optic chiasma syndrome of tumoral etiology.
Badiu C; Serbănescu A; Coculescu M
Rom J Physiol; 1996; 33(1-4):91-100. PubMed ID: 9117342
[TBL] [Abstract][Full Text] [Related]
15. The suprasellar volume of nonfunctioning pituitary adenomas: a useful tool for predicting visual field deficits.
Bonomo G; Bertani GA; Carrabba GG; Ferrante E; Pluderi M; Guastella C; Pignataro L; Rampini P; Mantovani G; Locatelli M
Pituitary; 2020 Oct; 23(5):552-557. PubMed ID: 32562134
[TBL] [Abstract][Full Text] [Related]
16. [Transsphenoidal Microneurosurgery. Part 4: Neuroophthalmological cure in pituitary adenoma].
Oi S; Ciric IS
No Shinkei Geka; 1982 Nov; 10(11):1183-7. PubMed ID: 7155292
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
Monteiro ML; Zambon BK; Cunha LP
Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
[TBL] [Abstract][Full Text] [Related]
18. Visual disturbances in patients with pituitary adenoma.
Ikeda H; Yoshimoto T
Acta Neurol Scand; 1995 Aug; 92(2):157-60. PubMed ID: 7484065
[TBL] [Abstract][Full Text] [Related]
19. [Visual acuity outcome and recurrence in large or huge pituitary adenomas operated with transcranial approach: comparison between frontotemporal and interhemispheric approaches].
Kurokawa Y; Uede T; Niwa J; Daibo M; Hashi K
No Shinkei Geka; 1998 Sep; 26(9):813-21. PubMed ID: 9757458
[TBL] [Abstract][Full Text] [Related]
20. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
